Insider Selling: Ralliant (NYSE:RAL) CEO Sells 12,936 Shares

Ralliant Corporation (NYSE:RAL) CEO Tamara Newcombe sold 12,936 shares of Ralliant stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at $18,088,710.93. The trade was a 4.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ralliant Stock Performance

RAL traded down $2.54 on Tuesday, reaching $69.42. The company had a trading volume of 1,336,205 shares, compared to its average volume of 1,694,804. The stock has a market cap of $7.68 billion, a P/E ratio of -6.40, a P/E/G ratio of 2.69 and a beta of 1.61. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $75.41. The company’s fifty day moving average is $68.82 and its 200 day moving average is $55.58.

Ralliant (NYSE:RAL) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, analysts predict that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Institutional Investors Weigh In On Ralliant

Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in Ralliant during the second quarter worth approximately $1,039,481,000. Viking Global Investors LP acquired a new position in Ralliant in the 2nd quarter valued at $257,200,000. State Street Corp bought a new stake in shares of Ralliant during the 2nd quarter valued at $213,096,000. Millennium Management LLC grew its holdings in shares of Ralliant by 172.4% during the 4th quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after purchasing an additional 3,147,660 shares in the last quarter. Finally, Flossbach Von Storch SE acquired a new stake in shares of Ralliant during the 2nd quarter worth $222,460,000.

Wall Street Analyst Weigh In

Several analysts recently issued reports on RAL shares. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a research note on Friday, July 31st. Truist Financial reiterated a “buy” rating and set a $82.00 price objective (up from $68.00) on shares of Ralliant in a research report on Friday, July 31st. Zacks Research raised Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Wall Street Zen cut shares of Ralliant from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, August 11th. Finally, Oppenheimer upped their price target on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $75.70.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.